Market Research Logo

Ophthalmology Drug Development Pipeline Review, 2016

Ophthalmology Drug Development Pipeline Review, 2016

Summary


Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, and particularly blindness, can arise. Although there are a number of treatments approved in ophthalmology, there are currently no curative therapies for any of these indications. In particular, there are strong unmet needs within age-related macular degeneration and glaucoma, which can lead to blindness if not adequately treated.

Although there is a high degree of failure and uncertainty within the R&D of pharmaceuticals, there is a great deal of interest in ophthalmology development. Overall, there are over 700 products in active development in the ophthalmology therapy area, making it one of the largest therapy area pipelines.

Although two thirds of products in development for ophthalmology disorders are at the Discovery or Preclinical stage of development, the number of drugs in the pipeline is very high, creating strong potential for a blockbuster drug to enter the market.

The report provides comprehensive information on the pipeline development landscape for glaucoma, age-related macular degeneration, diabetic retinopathy, diabetic macular edema and keratoconjunctivitis sicca (dry eye), from Discovery through to the Pre-Registration stage. This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type. A list of all products in development is provided, including dormant and discontinued projects. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.

Scope

  • Which companies are the most active within the pipeline for ophthalmology?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have occurred in ophthalmology?
Reasons to buy
  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication.
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each.
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these.
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration.


  • GBI Research Report Guidance
  • Executive Summary
  • Introduction
    • Ophthalmology Therapeutics Report Coverage
      • Age Related Macular Degeneration
      • Age Related Macular Degeneration Overview
      • Diabetic Retinopathy
      • Diabetic Retinopathy Overview
      • Diabetic Macular Edema
      • Diabetic Macular Edema Overview
      • Keratoconjunctivitis sicca (Dry Eye)
      • Keratoconjunctivitis sicca (Dry Eye) Overview
      • Glaucoma
      • Glaucoma Overview
  • Therapeutics Development by Stage
    • Age Related Macular Degeneration
      • Pipeline Products for Age Related Macular Degeneration - Overview
        • Table Figure 1: Number of Products under Development for Age Related Macular Degeneration
        • Table Number of Products under Development for Age Related Macular Degeneration
      • Pipeline Products for Age Related Macular Degeneration - Comparative Analysis
        • Table Figure 2: Number of Products under Development for Age Related Macular Degeneration - Comparative Analysis
        • Table Number of Products under Development for Age Related Macular Degeneration - Comparative Analysis
    • Diabetic Retinopathy
      • Pipeline Products for Diabetic Retinopathy - Overview
        • Table Figure 3: Number of Products under Development for Diabetic Retinopathy
        • Table Number of Products under Development for Diabetic Retinopathy
      • Pipeline Products for Diabetic Retinopathy - Comparative Analysis
        • Table Figure 4: Number of Products under Development for Diabetic Retinopathy - Comparative Analysis
        • Table Number of Products under Development for Diabetic Retinopathy - Comparative Analysis
    • Diabetic Macular Edema
      • Pipeline Products for Diabetic Macular Edema - Overview
        • Table Figure 5: Number of Products under Development for Diabetic Macular Edema
        • Table Number of Products under Development for Diabetic Macular Edema
      • Pipeline Products for Diabetic Macular Edema - Comparative Analysis
        • Table Figure 6: Number of Products under Development for Diabetic Macular Edema – Comparative Analysis
        • Table Number of Products under Development for Diabetic Macular Edema – Comparative Analysis
    • Keratoconjunctivitis sicca (Dry Eye)
      • Pipeline Products for Keratoconjunctivitis sicca (Dry Eye) - Overview
        • Table Figure 7: Number of Products under Development for Keratoconjunctivitis sicca (Dry Eye)
        • Table Number of Products under Development for Keratoconjunctivitis sicca (Dry Eye)
      • Pipeline Products for Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis
        • Table Figure 8: Number of Products under Development for Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis
        • Table Number of Products under Development for Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis
    • Glaucoma
      • Pipeline Products for Glaucoma - Overview
        • Table Figure 9: Number of Products under Development for Glaucoma, H2 2016
        • Table Number of Products under Development for Glaucoma, H2 2016
      • Pipeline Products for Glaucoma - Comparative Analysis
        • Table Figure 10: Number of Products under Development for Glaucoma - Comparative Analysis, H2 2016
        • Table Number of Products under Development for Glaucoma - Comparative Analysis, H2 2016
  • Therapeutics under Development by Companies
    • Age Related Macular Degeneration
      • Table Figure 11: Age Related Macular Degeneration - Number of Products under Development by Companies
      • Table Age Related Macular Degeneration - Number of Products under Development by Companies
    • Diabetic Retinopathy
      • Table Figure 12: Diabetic Retinopathy - Number of Products under Development by Companies
      • Table Diabetic Retinopathy - Number of Products under Development by Companies
    • Diabetic Macular Edema
      • Table Figure 13: Diabetic Macular Edema - Number of Products under Development by Companies
      • Table Diabetic Macular Edema - Number of Products under Development by Companies
    • Keratoconjunctivitis sicca (Dry Eye)
      • Table Figure 14: Keratoconjunctivitis sicca (Dry Eye) - Number of Products under Development by Companies
      • Table Keratoconjunctivitis sicca (Dry Eye) - Number of Products under Development by Companies
    • Glaucoma
      • Table Figure 15: Glaucoma - Number of Products under Development by Companies, H2 2016
      • Table Glaucoma - Number of Products under Development by Companies, H2 2016
  • Therapeutics under Investigation by Universities/Institutes
    • Age Related Macular Degeneration
      • Table Figure 16: Age Related Macular Degeneration - Number of Products under Investigation by Universities/Institutes
      • Table Age Related Macular Degeneration - Number of Products under Investigation by Universities/Institutes
    • Diabetic Retinopathy
      • Table Diabetic Retinopathy - Number of Products under Investigation by Universities/Institutes
    • Diabetic Macular Edema
      • Table Figure 17: Diabetic Macular Edema - Number of Products under Investigation by Universities/Institutes
      • Table Diabetic Macular Edema - Number of Products under Investigation by Universities/Institutes
    • Keratoconjunctivitis sicca (Dry Eye)
      • Table Keratoconjunctivitis sicca (Dry Eye) - Number of Products under Investigation by Universities/Institutes
    • Glaucoma
      • Table Figure 18: Glaucoma - Number of Products under Investigation by Universities/Institutes, H2 2016
      • Table Glaucoma - Number of Products under Investigation by Universities/Institutes, H2 2016
  • Pipeline Products Glance
    • Age Related Macular Degeneration
      • Late Stage Products
        • Table Figure 19: Comparative Analysis by Late Stage Development
        • Table Comparative Analysis by Late Stage Development
      • Clinical Stage Products
        • Table Figure 20: Comparative Analysis by Clinical Stage Development
        • Table Comparative Analysis by Clinical Stage Development
      • Early Stage Products
        • Table Figure 21: Comparative Analysis by Early Stage Products
        • Table Comparative Analysis by Early Stage Development
      • Unknown Stage Products
        • Table Comparative Analysis by Unknown Stage Development
    • Diabetic Retinopathy
      • Clinical Stage Products
        • Table Figure 22: Diabetic Retinopathy - Comparative Analysis by Clinical Stage Development
        • Table Diabetic Retinopathy - Comparative Analysis by Clinical Stage Development
      • Early Stage Products
        • Table Figure 23: Diabetic Retinopathy - Comparative Analysis by Early Stage Products
        • Table Diabetic Retinopathy - Comparative Analysis by Early Stage Development
      • Unknown Stage Products
        • Table Diabetic Retinopathy - Comparative Analysis by Unknown Stage Development
    • Diabetic Macular Edema
      • Late Stage Products
        • Table Figure 24: Diabetic Macular Edema - Comparative Analysis by Late Stage Development
        • Table Diabetic Macular Edema - Comparative Analysis by Late Stage Development
      • Clinical Stage Products
        • Table Figure 25: Diabetic Macular Edema - Comparative Analysis by Clinical Stage Development
        • Table Diabetic Macular Edema - Comparative Analysis by Clinical Stage Development
      • Early Stage Products
        • Table Figure 26: Diabetic Macular Edema - Comparative Analysis by Early Stage Products
        • Table Diabetic Macular Edema - Comparative Analysis by Early Stage Development
      • Unknown Stage Products
        • Table Diabetic Macular Edema - Comparative Analysis by Unknown Stage Development
    • Keratoconjunctivitis sicca (Dry Eye)
      • Late Stage Products
        • Table Figure 27: Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis by Late Stage Development
        • Table Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis by Late Stage Development
      • Clinical Stage Products
        • Table Figure 28: Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis by Clinical Stage Development
        • Table Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis by Clinical Stage Development
      • Early Stage Products
        • Table Figure 29: Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis by Early Stage Products
        • Table Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis by Early Stage Development
      • Unknown Stage Products
        • Table Keratoconjunctivitis sicca (Dry Eye) - Comparative Analysis by Unknown Stage Development
    • Glaucoma
      • Late Stage Products
        • Table Figure 30: Glaucoma - Comparative Analysis by Late Stage Development, H2 2016
        • Table Glaucoma - Comparative Analysis by Late Stage Development, H2 2016
      • Clinical Stage Products
        • Table Figure 31: Glaucoma - Comparative Analysis by Clinical Stage Development, H2 2016
        • Table Glaucoma - Comparative Analysis by Clinical Stage Development, H2 2016
      • Early Stage Products
        • Table Figure 32: Glaucoma - Comparative Analysis by Early Stage Products, H2 2016
        • Table Glaucoma - Comparative Analysis by Early Stage Development, H2 2016
      • Unknown Stage Products
        • Table Figure 33: Glaucoma - Comparative Analysis by Unknown Stage Development, H2 2016
        • Table Glaucoma - Comparative Analysis by Unknown Stage Development, H2 2016
  • Products under Development by Companies
    • Age Related Macular Degeneration
      • Table Products under Development by Companies
    • Diabetic Retinopathy
      • Table Diabetic Retinopathy - Products under Development by Companies
    • Diabetic Macular Edema
      • Table Diabetic Macular Edema - Products under Development by Companies
    • Keratoconjunctivitis sicca (Dry Eye)
      • Table Keratoconjunctivitis sicca (Dry Eye) - Products under Development by Companies
    • Glaucoma
      • Table Glaucoma - Products under Development by Companies, H2 2016
  • Products under Investigation by Universities/Institutes
    • Age Related Macular Degeneration
      • Table Age Related Macular Degeneration - Products under Investigation by Universities/Institutes
    • Diabetic Retinopathy
      • Table Diabetic Retinopathy - Products under Investigation by Universities/Institutes
    • Diabetic Macular Edema
      • Table Diabetic Macular Edema - Products under Investigation by Universities/Institutes
    • Keratoconjunctivitis sicca (Dry Eye)
      • Table Keratoconjunctivitis sicca (Dry Eye) - Products under Investigation by Universities/Institutes
    • Glaucoma
      • Table Glaucoma - Products under Investigation by Universities/Institutes, H2 2016
  • Companies Involved in Therapeutics Development
    • Age Related Macular Degeneration
      • AC Immune SA
        • Table Age Related Macular Degeneration - Pipeline by AC Immune SA
      • Achillion Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Achillion Pharmaceuticals, Inc.
      • Aciont Inc.
        • Table Age Related Macular Degeneration - Pipeline by Aciont Inc.
      • AdAlta Pty Ltd.
        • Table Age Related Macular Degeneration - Pipeline by AdAlta Pty Ltd.
      • Adverum Biotechnologies, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Adverum Biotechnologies, Inc.
      • Aerie Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Aerie Pharmaceuticals, Inc.
      • Aerpio Therapeutics, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Aerpio Therapeutics, Inc.
      • Alimera Sciences, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Alimera Sciences, Inc.
      • Alkeus Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Alkeus Pharmaceuticals, Inc.
      • Allergan Plc
        • Table Age Related Macular Degeneration - Pipeline by Allergan Plc
      • Allinky Biopharma
        • Table Age Related Macular Degeneration - Pipeline by Allinky Biopharma
      • Alteogen Inc.
        • Table Age Related Macular Degeneration - Pipeline by Alteogen Inc.
      • Amakem NV
        • Table Age Related Macular Degeneration - Pipeline by Amakem NV
      • Amarna Therapeutics B.V.
        • Table Age Related Macular Degeneration - Pipeline by Amarna Therapeutics B.V.
      • Ampio Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Ampio Pharmaceuticals, Inc.
      • Amyndas Pharmaceuticals LLC
        • Table Age Related Macular Degeneration - Pipeline by Amyndas Pharmaceuticals LLC
      • Apellis Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Apellis Pharmaceuticals, Inc.
      • Apexigen, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Apexigen, Inc.
      • Applied Genetic Technologies Corporation
        • Table Age Related Macular Degeneration - Pipeline by Applied Genetic Technologies Corporation
      • Astellas Pharma Inc.
        • Table Age Related Macular Degeneration - Pipeline by Astellas Pharma Inc.
      • Benitec Biopharma Limited
        • Table Age Related Macular Degeneration - Pipeline by Benitec Biopharma Limited
      • BIOCAD
        • Table Age Related Macular Degeneration - Pipeline by BIOCAD
      • Biokine Therapeutics Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Biokine Therapeutics Ltd.
      • BioMAS Ltd.
        • Table Age Related Macular Degeneration - Pipeline by BioMAS Ltd.
      • Biomics Biotechnologies Co., Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Biomics Biotechnologies Co., Ltd.
      • Biophytis SAS
        • Table Age Related Macular Degeneration - Pipeline by Biophytis SAS
      • Boehringer Ingelheim GmbH
        • Table Age Related Macular Degeneration - Pipeline by Boehringer Ingelheim GmbH
      • Caladrius Biosciences, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Caladrius Biosciences, Inc.
      • Catalyst Biosciences, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Catalyst Biosciences, Inc.
      • Cell Cure Neurosciences, Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Cell Cure Neurosciences, Ltd.
      • Charlesson LLC.
        • Table Age Related Macular Degeneration - Pipeline by Charlesson LLC.
      • Cipla Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Cipla Ltd.
      • Clanotech AB
        • Table Age Related Macular Degeneration - Pipeline by Clanotech AB
      • Clearside BioMedical, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Clearside BioMedical, Inc.
      • Clonz Biotech Private Limited
        • Table Age Related Macular Degeneration - Pipeline by Clonz Biotech Private Limited
      • Coherus BioSciences, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Coherus BioSciences, Inc.
      • Colby Pharmaceutical Company
        • Table Age Related Macular Degeneration - Pipeline by Colby Pharmaceutical Company
      • Crinetics Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Crinetics Pharmaceuticals, Inc.
      • Critical Pharmaceuticals Limited
        • Table Age Related Macular Degeneration - Pipeline by Critical Pharmaceuticals Limited
      • Daiichi Sankyo Company, Limited
        • Table Age Related Macular Degeneration - Pipeline by Daiichi Sankyo Company, Limited
      • Delenex Therapeutics AG
        • Table Age Related Macular Degeneration - Pipeline by Delenex Therapeutics AG
      • Diffusion Pharmaceuticals Inc.
        • Table Age Related Macular Degeneration - Pipeline by Diffusion Pharmaceuticals Inc.
      • Digna Biotech, S.L.
        • Table Age Related Macular Degeneration - Pipeline by Digna Biotech, S.L.
      • Eleven Biotherapeutics Inc.
        • Table Age Related Macular Degeneration - Pipeline by Eleven Biotherapeutics Inc.
      • Elsalys Biotech SAS
        • Table Age Related Macular Degeneration - Pipeline by Elsalys Biotech SAS
      • Exonate Limited
        • Table Age Related Macular Degeneration - Pipeline by Exonate Limited
      • F. Hoffmann-La Roche Ltd.
        • Table Age Related Macular Degeneration - Pipeline by F. Hoffmann-La Roche Ltd.
      • Foamix Pharmaceuticals Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Foamix Pharmaceuticals Ltd.
      • Formycon AG
        • Table Age Related Macular Degeneration - Pipeline by Formycon AG
      • Gene Techno Science Co., Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Gene Techno Science Co., Ltd.
      • Genentech, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Genentech, Inc.
      • GenSight Biologics S.A.
        • Table Age Related Macular Degeneration - Pipeline by GenSight Biologics S.A.
      • GlaxoSmithKline Plc
        • Table Age Related Macular Degeneration - Pipeline by GlaxoSmithKline Plc
      • Grupo Ferrer Internacional, S.A.
        • Table Age Related Macular Degeneration - Pipeline by Grupo Ferrer Internacional, S.A.
      • GTx, Inc.
        • Table Age Related Macular Degeneration - Pipeline by GTx, Inc.
      • HanAll Biopharma Co., Ltd.
        • Table Age Related Macular Degeneration - Pipeline by HanAll Biopharma Co., Ltd.
      • Huabo Biopharm Co., Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Huabo Biopharm Co., Ltd.
      • iCo Therapeutics Inc.
        • Table Age Related Macular Degeneration - Pipeline by iCo Therapeutics Inc.
      • Icon Bioscience, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Icon Bioscience, Inc.
      • Iconic Therapeutics, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Iconic Therapeutics, Inc.
      • Innovent Biologics, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Innovent Biologics, Inc.
      • Intellect Neurosciences, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Intellect Neurosciences, Inc.
      • International Stem Cell Corporation
        • Table Age Related Macular Degeneration - Pipeline by International Stem Cell Corporation
      • Ionis Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Ionis Pharmaceuticals, Inc.
      • Jeil Pharmaceutical Co., Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Jeil Pharmaceutical Co., Ltd.
      • Johnson & Johnson
        • Table Age Related Macular Degeneration - Pipeline by Johnson & Johnson
      • Kadmon Corporation, LLC
        • Table Age Related Macular Degeneration - Pipeline by Kadmon Corporation, LLC
      • Kala Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Kala Pharmaceuticals, Inc.
      • Kodiak Sciences, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Kodiak Sciences, Inc.
      • LeadArtis S.L.
        • Table Age Related Macular Degeneration - Pipeline by LeadArtis S.L.
      • M's Science Corporation
        • Table Age Related Macular Degeneration - Pipeline by M's Science Corporation
      • Mabion SA
        • Table Age Related Macular Degeneration - Pipeline by Mabion SA
      • MacuCLEAR, Inc.
        • Table Age Related Macular Degeneration - Pipeline by MacuCLEAR, Inc.
      • Mitotech S.A.
        • Table Age Related Macular Degeneration - Pipeline by Mitotech S.A.
      • Mitsubishi Tanabe Pharma Corporation
        • Table Age Related Macular Degeneration - Pipeline by Mitsubishi Tanabe Pharma Corporation
      • Navigen Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Navigen Pharmaceuticals, Inc.
      • Navya Biologicals Pvt Ltd
        • Table Age Related Macular Degeneration - Pipeline by Navya Biologicals Pvt Ltd
      • Neovacs SA
        • Table Age Related Macular Degeneration - Pipeline by Neovacs SA
      • Neumedicines Inc.
        • Table Age Related Macular Degeneration - Pipeline by Neumedicines Inc.
      • Neuroptis Biotech
        • Table Age Related Macular Degeneration - Pipeline by Neuroptis Biotech
      • Neurotech Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Neurotech Pharmaceuticals, Inc.
      • Novartis AG
        • Table Age Related Macular Degeneration - Pipeline by Novartis AG
      • Ocular Therapeutix, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Ocular Therapeutix, Inc.
      • Ohr Pharmaceutical Inc.
        • Table Age Related Macular Degeneration - Pipeline by Ohr Pharmaceutical Inc.
      • Omeros Corporation
        • Table Age Related Macular Degeneration - Pipeline by Omeros Corporation
      • Ophthotech Corp.
        • Table Age Related Macular Degeneration - Pipeline by Ophthotech Corp.
      • Orphagen Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Orphagen Pharmaceuticals, Inc.
      • Oxford BioMedica Plc
        • Table Age Related Macular Degeneration - Pipeline by Oxford BioMedica Plc
      • PanOptica, Inc.
        • Table Age Related Macular Degeneration - Pipeline by PanOptica, Inc.
      • Pfenex Inc.
        • Table Age Related Macular Degeneration - Pipeline by Pfenex Inc.
      • Pfizer Inc.
        • Table Age Related Macular Degeneration - Pipeline by Pfizer Inc.
      • Precision Ocular Ltd
        • Table Age Related Macular Degeneration - Pipeline by Precision Ocular Ltd
      • Promedior, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Promedior, Inc.
      • pSivida Corp.
        • Table Age Related Macular Degeneration - Pipeline by pSivida Corp.
      • QLT Inc.
        • Table Age Related Macular Degeneration - Pipeline by QLT Inc.
      • Quark Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Quark Pharmaceuticals, Inc.
      • Ra Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Ra Pharmaceuticals, Inc.
      • Regeneron Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Regeneron Pharmaceuticals, Inc.
      • RegenxBio Inc.
        • Table Age Related Macular Degeneration - Pipeline by RegenxBio Inc.
      • Ribomic Inc.
        • Table Age Related Macular Degeneration - Pipeline by Ribomic Inc.
      • RXi Pharmaceuticals Corporation
        • Table Age Related Macular Degeneration - Pipeline by RXi Pharmaceuticals Corporation
      • SanBio, Inc.
        • Table Age Related Macular Degeneration - Pipeline by SanBio, Inc.
      • Santen Pharmaceutical Co., Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Santen Pharmaceutical Co., Ltd.
      • Sanwa Kagaku Kenkyusho Co., Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Sanwa Kagaku Kenkyusho Co., Ltd.
      • SciFluor Life Sciences, LLC
        • Table Age Related Macular Degeneration - Pipeline by SciFluor Life Sciences, LLC
      • Sirnaomics, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Sirnaomics, Inc.
      • Stealth BioTherapeutics Inc.
        • Table Age Related Macular Degeneration - Pipeline by Stealth BioTherapeutics Inc.
      • Sucampo Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Sucampo Pharmaceuticals, Inc.
      • Sumitomo Dainippon Pharma Co., Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Sumitomo Dainippon Pharma Co., Ltd.
      • Sun Pharma Advanced Research Company Ltd.
        • Table Age Related Macular Degeneration - Pipeline by Sun Pharma Advanced Research Company Ltd.
      • TRACON Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by TRACON Pharmaceuticals, Inc.
      • TWi Pharmaceuticals, Inc.
        • Table Age Related Macular Degeneration - Pipeline by TWi Pharmaceuticals, Inc.
      • Tyrogenex, Inc.
        • Table Age Related Macular Degeneration - Pipeline by Tyrogenex, Inc.
      • VasGene Therapeutics, Inc.
        • Table Age Related Macular Degeneration - Pipeline by VasGene Therapeutics, Inc.
      • Wellstat Ophthalmics Corporation
        • Table Age Related Macular Degeneration - Pipeline by Wellstat Ophthalmics Corporation
      • Xbrane Biopharma AB
        • Table Age Related Macular Degeneration - Pipeline by Xbrane Biopharma AB
    • Diabetic Retinopathy
      • Acucela Inc.
        • Table Diabetic Retinopathy - Pipeline by Acucela Inc.
      • Aerie Pharmaceuticals, Inc.
        • Table Diabetic Retinopathy - Pipeline by Aerie Pharmaceuticals, Inc.
      • Aerpio Therapeutics, Inc.
        • Table Diabetic Retinopathy - Pipeline by Aerpio Therapeutics, Inc.
      • Antisense Therapeutics Limited
        • Table Diabetic Retinopathy - Pipeline by Antisense Therapeutics Limited
      • BCN Peptides, S.A.
        • Table Diabetic Retinopathy - Pipeline by BCN Peptides, S.A.
      • Biomar Microbial Technologies
        • Table Diabetic Retinopathy - Pipeline by Biomar Microbial Technologies
      • Charlesson LLC.
        • Table Diabetic Retinopathy - Pipeline by Charlesson LLC.
      • Coherus BioSciences, Inc.
        • Table Diabetic Retinopathy - Pipeline by Coherus BioSciences, Inc.
      • Crinetics Pharmaceuticals, Inc.
        • Table Diabetic Retinopathy - Pipeline by Crinetics Pharmaceuticals, Inc.
      • Diffusion Pharmaceuticals Inc.
        • Table Diabetic Retinopathy - Pipeline by Diffusion Pharmaceuticals Inc.
      • Dimerix Bioscience Pty Ltd
        • Table Diabetic Retinopathy - Pipeline by Dimerix Bioscience Pty Ltd
      • Dynamis Therapeutics, Inc.
        • Table Diabetic Retinopathy - Pipeline by Dynamis Therapeutics, Inc.
      • EyeGene, Inc.
        • Table Diabetic Retinopathy - Pipeline by EyeGene, Inc.
      • Foresee Pharmaceuticals, LLC
        • Table Diabetic Retinopathy - Pipeline by Foresee Pharmaceuticals, LLC
      • GTx, Inc.
        • Table Diabetic Retinopathy - Pipeline by GTx, Inc.
      • Icon Bioscience, Inc.
        • Table Diabetic Retinopathy - Pipeline by Icon Bioscience, Inc.
      • Islet Sciences, Inc.
        • Table Diabetic Retinopathy - Pipeline by Islet Sciences, Inc.
      • Kodiak Sciences, Inc.
        • Table Diabetic Retinopathy - Pipeline by Kodiak Sciences, Inc.
      • Kowa Company, Ltd.
        • Table Diabetic Retinopathy - Pipeline by Kowa Company, Ltd.
      • LegoChem Biosciences, Inc
        • Table Diabetic Retinopathy - Pipeline by LegoChem Biosciences, Inc
      • Lpath, Inc.
        • Table Diabetic Retinopathy - Pipeline by Lpath, Inc.
      • M's Science Corporation
        • Table Diabetic Retinopathy - Pipeline by M's Science Corporation
      • Mabion SA
        • Table Diabetic Retinopathy - Pipeline by Mabion SA
      • MingSight Pharmaceuticals
        • Table Diabetic Retinopathy - Pipeline by MingSight Pharmaceuticals
      • OcuCure Therapeutics, Inc.
        • Table Diabetic Retinopathy - Pipeline by OcuCure Therapeutics, Inc.
      • Oculis ehf
        • Table Diabetic Retinopathy - Pipeline by Oculis ehf
      • Ohr Pharmaceutical Inc.
        • Table Diabetic Retinopathy - Pipeline by Ohr Pharmaceutical Inc.
      • PanOptica, Inc.
        • Table Diabetic Retinopathy - Pipeline by PanOptica, Inc.
      • Promedior, Inc.
        • Table Diabetic Retinopathy - Pipeline by Promedior, Inc.
      • Ribomic Inc.
        • Table Diabetic Retinopathy - Pipeline by Ribomic Inc.
      • Sirnaomics, Inc.
        • Table Diabetic Retinopathy - Pipeline by Sirnaomics, Inc.
      • Stelic Institute & Co., Inc.
        • Table Diabetic Retinopathy - Pipeline by Stelic Institute & Co., Inc.
      • Stemedica Cell Technologies, Inc.
        • Table Diabetic Retinopathy - Pipeline by Stemedica Cell Technologies, Inc.
      • Strongbridge Biopharma plc
        • Table Diabetic Retinopathy - Pipeline by Strongbridge Biopharma plc
      • Sucampo Pharmaceuticals, Inc.
        • Table Diabetic Retinopathy - Pipeline by Sucampo Pharmaceuticals, Inc.
      • Targazyme, Inc.
        • Table Diabetic Retinopathy - Pipeline by Targazyme, Inc.
      • ThromboGenics NV
        • Table Diabetic Retinopathy - Pipeline by ThromboGenics NV
      • TWi Pharmaceuticals, Inc.
        • Table Diabetic Retinopathy - Pipeline by TWi Pharmaceuticals, Inc.
      • UAB Profarma
        • Table Diabetic Retinopathy - Pipeline by UAB Profarma
      • VasGene Therapeutics, Inc.
        • Table Diabetic Retinopathy - Pipeline by VasGene Therapeutics, Inc.
      • Xbrane Biopharma AB
        • Table Diabetic Retinopathy - Pipeline by Xbrane Biopharma AB
    • Diabetic Macular Edema
      • Aciont Inc.
        • Table Diabetic Macular Edema - Pipeline by Aciont Inc.
      • ActiveSite Pharmaceuticals, Inc.
        • Table Diabetic Macular Edema - Pipeline by ActiveSite Pharmaceuticals, Inc.
      • Adverum Biotechnologies, Inc.
        • Table Diabetic Macular Edema - Pipeline by Adverum Biotechnologies, Inc.
      • Aerpio Therapeutics, Inc.
        • Table Diabetic Macular Edema - Pipeline by Aerpio Therapeutics, Inc.
      • Allergan Plc
        • Table Diabetic Macular Edema - Pipeline by Allergan Plc
      • Ampio Pharmaceuticals, Inc.
        • Table Diabetic Macular Edema - Pipeline by Ampio Pharmaceuticals, Inc.
      • Araim Pharmaceuticals, Inc.
        • Table Diabetic Macular Edema - Pipeline by Araim Pharmaceuticals, Inc.
      • Astellas Pharma Inc.
        • Table Diabetic Macular Edema - Pipeline by Astellas Pharma Inc.
      • Boehringer Ingelheim GmbH
        • Table Diabetic Macular Edema - Pipeline by Boehringer Ingelheim GmbH
      • Chengdu Kanghong Pharmaceuticals Group Co., Ltd.
        • Table Diabetic Macular Edema - Pipeline by Chengdu Kanghong Pharmaceuticals Group Co., Ltd.
      • Clonz Biotech Private Limited
        • Table Diabetic Macular Edema - Pipeline by Clonz Biotech Private Limited
      • Coherus BioSciences, Inc.
        • Table Diabetic Macular Edema - Pipeline by Coherus BioSciences, Inc.
      • EyeGate Pharmaceuticals, Inc.
        • Table Diabetic Macular Edema - Pipeline by EyeGate Pharmaceuticals, Inc.
      • EyeGene, Inc.
        • Table Diabetic Macular Edema - Pipeline by EyeGene, Inc.
      • F. Hoffmann-La Roche Ltd.
        • Table Diabetic Macular Edema - Pipeline by F. Hoffmann-La Roche Ltd.
      • Formycon AG
        • Table Diabetic Macular Edema - Pipeline by Formycon AG
      • Genmab A/S
        • Table Diabetic Macular Edema - Pipeline by Genmab A/S
      • Icon Bioscience, Inc.
        • Table Diabetic Macular Edema - Pipeline by Icon Bioscience, Inc.
      • Kala Pharmaceuticals, Inc.
        • Table Diabetic Macular Edema - Pipeline by Kala Pharmaceuticals, Inc.
      • Kalvista Pharmaceuticals Ltd
        • Table Diabetic Macular Edema - Pipeline by Kalvista Pharmaceuticals Ltd
      • Kowa Company, Ltd.
        • Table Diabetic Macular Edema - Pipeline by Kowa Company, Ltd.
      • Mabion SA
        • Table Diabetic Macular Edema - Pipeline by Mabion SA
      • NicOx S.A.
        • Table Diabetic Macular Edema - Pipeline by NicOx S.A.
      • Oculis ehf
        • Table Diabetic Macular Edema - Pipeline by Oculis ehf
      • Ohr Pharmaceutical Inc.
        • Table Diabetic Macular Edema - Pipeline by Ohr Pharmaceutical Inc.
      • Pfizer Inc.
        • Table Diabetic Macular Edema - Pipeline by Pfizer Inc.
      • Precision Ocular Ltd
        • Table Diabetic Macular Edema - Pipeline by Precision Ocular Ltd
      • pSivida Corp.
        • Table Diabetic Macular Edema - Pipeline by pSivida Corp.
      • Regeneron Pharmaceuticals, Inc.
        • Table Diabetic Macular Edema - Pipeline by Regeneron Pharmaceuticals, Inc.
      • Santen Pharmaceutical Co., Ltd.
        • Table Diabetic Macular Edema - Pipeline by Santen Pharmaceutical Co., Ltd.
      • SciFluor Life Sciences, LLC
        • Table Diabetic Macular Edema - Pipeline by SciFluor Life Sciences, LLC
      • Senju Pharmaceutical Co., Ltd.
        • Table Diabetic Macular Edema - Pipeline by Senju Pharmaceutical Co., Ltd.
      • Stealth BioTherapeutics Inc.
        • Table Diabetic Macular Edema - Pipeline by Stealth BioTherapeutics Inc.
      • Sucampo Pharmaceuticals, Inc.
        • Table Diabetic Macular Edema - Pipeline by Sucampo Pharmaceuticals, Inc.
      • ThromboGenics NV
        • Table Diabetic Macular Edema - Pipeline by ThromboGenics NV
      • Verseon Corporation
        • Table Diabetic Macular Edema - Pipeline by Verseon Corporation
      • Xbrane Biopharma AB
        • Table Diabetic Macular Edema - Pipeline by Xbrane Biopharma AB
    • Keratoconjunctivitis sicca (Dry Eye)
      • AB2 Bio Ltd.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by AB2 Bio Ltd.
      • Allergan Plc
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Allergan Plc
      • Ascendia Pharmaceuticals LLC
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Ascendia Pharmaceuticals LLC
      • Chong Kun Dang Pharmaceutical Corp.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Chong Kun Dang Pharmaceutical Corp.
      • Digna Biotech, S.L.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Digna Biotech, S.L.
      • Dompe Farmaceutici S.p.A.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Dompe Farmaceutici S.p.A.
      • HanAll Biopharma Co., Ltd.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by HanAll Biopharma Co., Ltd.
      • Herantis Pharma Plc
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Herantis Pharma Plc
      • Huons Co., Ltd.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Huons Co., Ltd.
      • InSite Vision Incorporated
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by InSite Vision Incorporated
      • Kala Pharmaceuticals, Inc.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Kala Pharmaceuticals, Inc.
      • Kissei Pharmaceutical Co., Ltd.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Kissei Pharmaceutical Co., Ltd.
      • KPI Therapeutics, Inc.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by KPI Therapeutics, Inc.
      • Kukje Pharmaceutical Industry Co., Ltd.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Kukje Pharmaceutical Industry Co., Ltd.
      • Laboratoires Thea S.A.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Laboratoires Thea S.A.
      • Lee's Pharmaceutical Holdings Limited
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Lee's Pharmaceutical Holdings Limited
      • Lipicard Technologies Limited
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Lipicard Technologies Limited
      • Merck & Co., Inc.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Merck & Co., Inc.
      • Mimetogen Pharmaceuticals Inc.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Mimetogen Pharmaceuticals Inc.
      • Mitotech S.A.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Mitotech S.A.
      • Nanomerics Ltd
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Nanomerics Ltd
      • Neuroptis Biotech
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Neuroptis Biotech
      • Novaliq GmbH
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Novaliq GmbH
      • Ocular Therapeutix, Inc.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Ocular Therapeutix, Inc.
      • Oculis ehf
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Oculis ehf
      • OncoNOx ApS
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by OncoNOx ApS
      • Otsuka Holdings Co., Ltd.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Otsuka Holdings Co., Ltd.
      • Parion Sciences, Inc.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Parion Sciences, Inc.
      • Quorum Innovations LLC
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Quorum Innovations LLC
      • RegeneRx Biopharmaceuticals, Inc.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by RegeneRx Biopharmaceuticals, Inc.
      • Rigel Pharmaceuticals, Inc.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Rigel Pharmaceuticals, Inc.
      • Samjin Pharmaceutical Co., Ltd.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Samjin Pharmaceutical Co., Ltd.
      • Santen Pharmaceutical Co., Ltd.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Santen Pharmaceutical Co., Ltd.
      • Seikagaku Corporation
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Seikagaku Corporation
      • Sucampo Pharmaceuticals, Inc.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Sucampo Pharmaceuticals, Inc.
      • TearSolutions, LLC.
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by TearSolutions, LLC.
      • TopiVert Ltd
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by TopiVert Ltd
      • Xigen SA
        • Table Keratoconjunctivitis sicca (Dry Eye) - Pipeline by Xigen SA
    • Glaucoma
      • AC Immune SA
        • Table Glaucoma - Pipeline by AC Immune SA, H2 2016
      • Acadia Pharmaceuticals Inc.
        • Table Glaucoma - Pipeline by Acadia Pharmaceuticals Inc., H2 2016
      • Advanced Refractive Technologies, Inc.
        • Table Glaucoma - Pipeline by Advanced Refractive Technologies, Inc., H2 2016
      • Aerie Pharmaceuticals, Inc.
        • Table Glaucoma - Pipeline by Aerie Pharmaceuticals, Inc., H2 2016
      • Allergan Plc
        • Table Glaucoma - Pipeline by Allergan Plc, H2 2016
      • Altacor Limited
        • Table Glaucoma - Pipeline by Altacor Limited, H2 2016
      • Amakem NV
        • Table Glaucoma - Pipeline by Amakem NV, H2 2016
      • Amarantus Bioscience Holdings, Inc.
        • Table Glaucoma - Pipeline by Amarantus Bioscience Holdings, Inc., H2 2016
      • Amgen Inc.
        • Table Glaucoma - Pipeline by Amgen Inc., H2 2016
      • Astellas Pharma Inc.
        • Table Glaucoma - Pipeline by Astellas Pharma Inc., H2 2016
      • Bausch & Lomb Incorporated
        • Table Glaucoma - Pipeline by Bausch & Lomb Incorporated, H2 2016
      • BioAxone BioSciences, Inc.
        • Table Glaucoma - Pipeline by BioAxone BioSciences, Inc., H2 2016
      • Bionure Farma, S.L.
        • Table Glaucoma - Pipeline by Bionure Farma, S.L., H2 2016
      • Coronis Partners Ltd.
        • Table Glaucoma - Pipeline by Coronis Partners Ltd., H2 2016
      • D. Western Therapeutics Institute, Inc.
        • Table Glaucoma - Pipeline by D. Western Therapeutics Institute, Inc., H2 2016
      • Dompe Farmaceutici S.p.A.
        • Table Glaucoma - Pipeline by Dompe Farmaceutici S.p.A., H2 2016
      • F. Hoffmann-La Roche Ltd.
        • Table Glaucoma - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016
      • Gilead Sciences, Inc.
        • Table Glaucoma - Pipeline by Gilead Sciences, Inc., H2 2016
      • Glaukos Corporation
        • Table Glaucoma - Pipeline by Glaukos Corporation, H2 2016
      • Graybug Vision Inc
        • Table Glaucoma - Pipeline by Graybug Vision Inc, H2 2016
      • Handok Inc.
        • Table Glaucoma - Pipeline by Handok Inc., H2 2016
      • HitGen LTD
        • Table Glaucoma - Pipeline by HitGen LTD, H2 2016
      • Icon Bioscience, Inc.
        • Table Glaucoma - Pipeline by Icon Bioscience, Inc., H2 2016
      • ID Pharma Co., Ltd.
        • Table Glaucoma - Pipeline by ID Pharma Co., Ltd., H2 2016
      • InMed Pharmaceuticals Inc.
        • Table Glaucoma - Pipeline by InMed Pharmaceuticals Inc., H2 2016
      • Inotek Pharmaceuticals Corporation
        • Table Glaucoma - Pipeline by Inotek Pharmaceuticals Corporation, H2 2016
      • InSite Vision Incorporated
        • Table Glaucoma - Pipeline by InSite Vision Incorporated, H2 2016
      • Ironwood Pharmaceuticals, Inc.
        • Table Glaucoma - Pipeline by Ironwood Pharmaceuticals, Inc., H2 2016
      • Isarna Therapeutics GmbH
        • Table Glaucoma - Pipeline by Isarna Therapeutics GmbH, H2 2016
      • Kala Pharmaceuticals, Inc.
        • Table Glaucoma - Pipeline by Kala Pharmaceuticals, Inc., H2 2016
      • Kowa Company, Ltd.
        • Table Glaucoma - Pipeline by Kowa Company, Ltd., H2 2016
      • Kukje Pharmaceutical Industry Co., Ltd.
        • Table Glaucoma - Pipeline by Kukje Pharmaceutical Industry Co., Ltd., H2 2016
      • Laboratoires Thea S.A.
        • Table Glaucoma - Pipeline by Laboratoires Thea S.A., H2 2016
      • Laboratorios Sophia S.A. de C.V.
        • Table Glaucoma - Pipeline by Laboratorios Sophia S.A. de C.V., H2 2016
      • Lee's Pharmaceutical Holdings Limited
        • Table Glaucoma - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2016
      • Lexicon Pharmaceuticals, Inc.
        • Table Glaucoma - Pipeline by Lexicon Pharmaceuticals, Inc., H2 2016
      • Merck & Co., Inc.
        • Table Glaucoma - Pipeline by Merck & Co., Inc., H2 2016
      • Nemus Bioscience, Inc.
        • Table Glaucoma - Pipeline by Nemus Bioscience, Inc., H2 2016
      • NicOx S.A.
        • Table Glaucoma - Pipeline by NicOx S.A., H2 2016
      • NoNO, Inc.
        • Table Glaucoma - Pipeline by NoNO, Inc., H2 2016
      • Novaliq GmbH
        • Table Glaucoma - Pipeline by Novaliq GmbH, H2 2016
      • Ocular Therapeutix, Inc.
        • Table Glaucoma - Pipeline by Ocular Therapeutix, Inc., H2 2016
      • Oculis ehf
        • Table Glaucoma - Pipeline by Oculis ehf, H2 2016
      • Ohr Pharmaceutical Inc.
        • Table Glaucoma - Pipeline by Ohr Pharmaceutical Inc., H2 2016
      • Otsuka Holdings Co., Ltd.
        • Table Glaucoma - Pipeline by Otsuka Holdings Co., Ltd., H2 2016
      • Oxford BioMedica Plc
        • Table Glaucoma - Pipeline by Oxford BioMedica Plc, H2 2016
      • Profarma
        • Table Glaucoma - Pipeline by Profarma, H2 2016
      • pSivida Corp.
        • Table Glaucoma - Pipeline by pSivida Corp., H2 2016
      • Quark Pharmaceuticals, Inc.
        • Table Glaucoma - Pipeline by Quark Pharmaceuticals, Inc., H2 2016
      • Quethera Limited
        • Table Glaucoma - Pipeline by Quethera Limited, H2 2016
      • Regeneron Pharmaceuticals Inc
        • Table Glaucoma - Pipeline by Regeneron Pharmaceuticals Inc, H2 2016
      • Sanofi
        • Table Glaucoma - Pipeline by Sanofi, H2 2016
      • Santen Pharmaceutical Co., Ltd.
        • Table Glaucoma - Pipeline by Santen Pharmaceutical Co., Ltd., H2 2016
      • Senju Pharmaceutical Co., Ltd.
        • Table Glaucoma - Pipeline by Senju Pharmaceutical Co., Ltd., H2 2016
      • Shire Plc
        • Table Glaucoma - Pipeline by Shire Plc, H2 2016
      • SK Biopharmaceuticals Co., Ltd.
        • Table Glaucoma - Pipeline by SK Biopharmaceuticals Co., Ltd., H2 2016
      • Sun Pharma Advanced Research Company Ltd.
        • Table Glaucoma - Pipeline by Sun Pharma Advanced Research Company Ltd., H2 2016
      • Sylentis S.A.U.
        • Table Glaucoma - Pipeline by Sylentis S.A.U., H2 2016
      • ViSci Ltd.
        • Table Glaucoma - Pipeline by ViSci Ltd., H2 2016
  • Therapeutics Assessment
    • Age Related Macular Degeneration
      • Assessment by Monotherapy Products
        • Table Figure 34: Assessment by Monotherapy Products
        • Table Assessment by Monotherapy Products
      • Assessment by Combination Products
        • Table Assessment by Combination Products
      • Assessment by Target
        • Table Figure 35: Number of Products by Top 10 Targets
        • Table Figure 36: Number of Products by Stage and Top 10 Targets
        • Table Number of Products by Stage and Target
      • Assessment by Mechanism of Action
        • Table Figure 37: Number of Products by Top 10 Mechanism of Actions
        • Table Figure 38: Number of Products by Stage and Top 10 Mechanism of Actions
        • Table Number of Products by Stage and Mechanism of Action
      • Assessment by Route of Administration
        • Table Figure 39: Number of Products by Top 10 Routes of Administration
        • Table Figure 40: Number of Products by Stage and Top 10 Routes of Administration
        • Table Number of Products by Stage and Route of Administration
      • Assessment by Molecule Type
        • Table Figure 41: Number of Products by Top 10 Molecule Types
        • Table Figure 42: Number of Products by Stage and Top 10 Molecule Types
        • Table Number of Products by Stage and Molecule Type
    • Diabetic Retinopathy
      • Assessment by Monotherapy Products
        • Table Figure 43: Diabetic Retinopathy - Assessment by Monotherapy Products
        • Table Diabetic Retinopathy - Assessment by Monotherapy Products
      • Assessment by Combination Products
        • Table Diabetic Retinopathy - Assessment by Combination Products
      • Assessment by Target
        • Table Figure 44: Diabetic Retinopathy - Number of Products by Top 10 Targets
        • Table Figure 45: Diabetic Retinopathy - Number of Products by Stage and Top 10 Targets
        • Table Diabetic Retinopathy - Number of Products by Stage and Target
      • Assessment by Mechanism of Action
        • Table Figure 46: Diabetic Retinopathy - Number of Products by Top 10 Mechanism of Actions
        • Table Figure 47: Diabetic Retinopathy - Number of Products by Stage and Top 10 Mechanism of Actions
        • Table Diabetic Retinopathy - Number of Products by Stage and Mechanism of Action
      • Assessment by Route of Administration
        • Table Figure 48: Diabetic Retinopathy - Number of Products by Top 10 Routes of Administration
        • Table Figure 49: Diabetic Retinopathy - Number of Products by Stage and Top 10 Routes of Administration
        • Table Diabetic Retinopathy - Number of Products by Stage and Route of Administration
      • Assessment by Molecule Type
        • Table Figure 50: Diabetic Retinopathy - Number of Products by Top 10 Molecule Types
        • Table Figure 51: Diabetic Retinopathy - Number of Products by Stage and Top 10 Molecule Types
        • Table Diabetic Retinopathy - Number of Products by Stage and Molecule Type
    • Diabetic Macular Edema
      • Assessment by Monotherapy Products
        • Table Figure 52: Diabetic Macular Edema - Assessment by Monotherapy Products
        • Table Diabetic Macular Edema - Assessment by Monotherapy Products
      • Assessment by Combination Products
        • Table Diabetic Macular Edema - Assessment by Combination Products
      • Assessment by Target
        • Table Figure 53: Diabetic Macular Edema - Number of Products by Top 10 Targets
        • Table Figure 54: Diabetic Macular Edema - Number of Products by Stage and Top 10 Targets
        • Table Diabetic Macular Edema - Number of Products by Stage and Target
      • Assessment by Mechanism of Action
        • Table Figure 55: Diabetic Macular Edema - Number of Products by Top 10 Mechanism of Actions
        • Table Figure 56: Diabetic Macular Edema - Number of Products by Stage and Top 10 Mechanism of Actions
        • Table Diabetic Macular Edema - Number of Products by Stage and Mechanism of Action
      • Assessment by Route of Administration
        • Table Figure 57: Diabetic Macular Edema - Number of Products by Routes of Administration
        • Table Figure 58: Diabetic Macular Edema - Number of Products by Stage and Routes of Administration
        • Table Diabetic Macular Edema - Number of Products by Stage and Route of Administration
      • Assessment by Molecule Type
        • Table Figure 59: Diabetic Macular Edema - Number of Products by Molecule Types
        • Table Figure 60: Diabetic Macular Edema - Number of Products by Stage and Molecule Types
        • Table Diabetic Macular Edema - Number of Products by Stage and Molecule Type
    • Keratoconjunctivitis sicca (Dry Eye)
      • Assessment by Monotherapy Products
        • Table Figure 61: Keratoconjunctivitis sicca (Dry Eye) - Assessment by Monotherapy Products
        • Table Keratoconjunctivitis sicca (Dry Eye) - Assessment by Monotherapy Products
      • Assessment by Target
        • Table Figure 62: Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Top 10 Targets
        • Table Figure 63: Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Stage and Top 10 Targets
        • Table Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Stage and Target
      • Assessment by Mechanism of Action
        • Table Figure 64: Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Top 10 Mechanism of Actions
        • Table Figure 65: Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Stage and Top 10 Mechanism of Actions
        • Table Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Stage and Mechanism of Action
      • Assessment by Route of Administration
        • Table Figure 66: Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Top 10 Routes of Administration
        • Table Figure 67: Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Stage and Top 10 Routes of Administration
        • Table Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Stage and Route of Administration
      • Assessment by Molecule Type
        • Table Figure 68: Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Molecule Types
        • Table Figure 69: Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Stage and Molecule Types
        • Table Keratoconjunctivitis sicca (Dry Eye) - Number of Products by Stage and Molecule Type
    • Glaucoma
      • Assessment by Monotherapy Products
        • Table Figure 70: Glaucoma - Assessment by Monotherapy Products, H2 2016
        • Table Glaucoma - Assessment by Monotherapy Products, H2 2016
      • Assessment by Combination Products
        • Table Figure 71: Glaucoma - Assessment by Combination Products, H2 2016
        • Table Glaucoma - Assessment by Combination Products, H2 2016
      • Assessment by Target
        • Table Figure 72: Glaucoma - Number of Products by Top 10 Targets, H2 2016
        • Table Figure 73: Glaucoma - Number of Products by Stage and Top 10 Targets, H2 2016
        • Table Glaucoma - Number of Products by Stage and Target, H2 2016
      • Assessment by Mechanism of Action
        • Table Figure 74: Glaucoma - Number of Products by Top 10 Mechanism of Actions, H2 2016
        • Table Figure 75: Glaucoma - Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
        • Table Glaucoma - Number of Products by Stage and Mechanism of Action, H2 2016
      • Assessment by Route of Administration
        • Table Figure 76: Glaucoma - Number of Products by Top 10 Routes of Administration, H2 2016
        • Table Figure 77: Glaucoma - Number of Products by Stage and Top 10 Routes of Administration, H2 2016
        • Table Glaucoma - Number of Products by Stage and Route of Administration, H2 2016
      • Assessment by Molecule Type
        • Table Figure 78: Glaucoma - Number of Products by Top 10 Molecule Types, H2 2016
        • Table Figure 79: Glaucoma - Number of Products by Stage and Top 10 Molecule Types, H2 2016
        • Table Glaucoma - Number of Products by Stage and Molecule Type, H2 2016
  • Recent Pipeline Updates
    • Age Related Macular Degeneration
      • Table Age Related Macular Degeneration Therapeutics - Recent Pipeline Updates
    • Diabetic Retinopathy
      • Table Diabetic Retinopathy Therapeutics - Recent Pipeline Updates
  • Dormant Projects
    • Age Related Macular Degeneration
      • Table Age Related Macular Degeneration - Dormant Projects
    • Diabetic Retinopathy
      • Table Diabetic Retinopathy - Dormant Projects
    • Diabetic Macular Edema
      • Table Diabetic Macular Edema - Dormant Projects
    • Keratoconjunctivitis sicca (Dry Eye)
      • Table Keratoconjunctivitis sicca (Dry Eye) - Dormant Projects
    • Glaucoma
      • Table Glaucoma - Dormant Projects, H2 2016
  • Discontinued Products
    • Age Related Macular Degeneration
      • Table Age Related Macular Degeneration - Discontinued Products
    • Diabetic Retinopathy
      • Table Diabetic Retinopathy - Discontinued Products
    • Diabetic Macular Edema
      • Table Diabetic Macular Edema - Discontinued Products
    • Keratoconjunctivitis sicca (Dry Eye)
      • Table Keratoconjunctivitis sicca (Dry Eye) - Discontinued Products
    • Glaucoma
      • Table Glaucoma - Discontinued Products, H2 2016
  • Product Development Milestones
    • Age Related Macular Degeneration
      • Featured News & Press Releases
    • Diabetic Retinopathy
      • Featured News & Press Releases
    • Diabetic Macular Edema
      • Featured News & Press Releases
    • Keratoconjunctivitis sicca (Dry Eye)
      • Featured News & Press Releases
    • Glaucoma
      • Featured News & Press Releases
  • Appendix
    • Research Methodology
    • Secondary Research
      • Pipeline Analysis
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report